{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:02:43Z","timestamp":1788314563749,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017567","name":"Apple Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ahj.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T02:09:17Z","timestamp":1673489357000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study"],"prefix":"10.1016","volume":"259","author":[{"given":"C. Michael","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Steinhubl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Passman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Schuyler","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jared","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ruskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun G.","family":"Tarakji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassir","family":"Marrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Harxhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrati","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeta","family":"Nikolovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wildenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.V.","family":"Damaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.01.004_bib0001","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/STROKEAHA.116.013378","article-title":"Global survey of the frequency of atrial fibrillation-associated stroke: embolic stroke of undetermined source global registry","volume":"47","author":"Perera","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2023.01.004_bib0002","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamacardio.2017.3180","article-title":"Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: The REVEAL AF Study","volume":"2","author":"Reiffel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.22667","article-title":"Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact","volume":"40","author":"Dilaveris","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0004","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/STROKEAHA.115.009930","article-title":"New appraisal of atrial fibrillation burden and stroke prevention","volume":"47","author":"Passman","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2023.01.004_bib0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamacardio.2021.3702","article-title":"Temporal association between episodes of atrial fibrillation and risk of ischemic stroke","volume":"6","author":"Singer","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2015.05.011","article-title":"Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age\/gender differences and cardiovascular outcomes","volume":"191","author":"Xiong","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0007","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/clc.23257","article-title":"Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation","volume":"42","author":"Tomasdottir","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0008","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/eurheartj\/ehz304","article-title":"Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation","volume":"40","author":"Friberg","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.004_bib0009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2020.10.075","article-title":"Age threshold for anticoagulation in patients with atrial fibrillation: a Swedish nationwide observational study","volume":"326","author":"Andersson","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0010","first-page":"1170","article-title":"2016 focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0011","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.004_bib0012","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.004_bib0013","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","article-title":"Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial","volume":"190","author":"Kirchhof","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.004_bib0014","unstructured":"National Institute for Health and Care Excellence. Atrial fibrillation: management. NICE Clinical Guideline [CG] 180. https:\/\/www.nice.org.uk\/guidance\/cg180. [accessed 7 September 2020]."},{"key":"10.1016\/j.ahj.2023.01.004_bib0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2021.23732","article-title":"Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement","volume":"327","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.01.004_bib0016","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.004_bib0017","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.112.098079","article-title":"A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions","volume":"126","author":"Charitos","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.004_bib0018","unstructured":"Pew Research Center. Mobile fact sheet. [accessed 17 June 2020]."},{"key":"10.1016\/j.ahj.2023.01.004_bib0019","unstructured":"Day S, Seninger C, Kothari M, et al. Digital health consumer adoption report 2019. https:\/\/mailchi.mp\/rockhealth\/consumer-adoption-report-2019. [accessed 23 July 2020]."},{"key":"10.1016\/j.ahj.2023.01.004_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2016.02.011","article-title":"Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: the mHealth Screening To Prevent Strokes (mSToPS) trial","volume":"175","author":"Steinhubl","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.004_bib0021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2018.8102","article-title":"Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: The mSToPS randomized clinical trial","volume":"320","author":"Steinhubl","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.01.004_bib0022","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.004_bib0023","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.004_bib0024","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.004_bib0025","unstructured":"Food and Drug Administration. De Novo classification request for ECG app. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/DEN180044.pdf. [accessed 9 July 2020]."},{"key":"10.1016\/j.ahj.2023.01.004_bib0026","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.004_bib0027","doi-asserted-by":"crossref","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ\u00a0Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2023.01.004_bib0028","doi-asserted-by":"crossref","first-page":"e003725","DOI":"10.1161\/JAHA.116.003725","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.01.004_bib0029","series-title":"Incentives and physical activity: an assessment of the association between Vitality's Active Rewards with Apple Watch benefit and sustained physical activity improvements","author":"Hafner","year":"2018"},{"key":"10.1016\/j.ahj.2023.01.004_bib0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41591-022-01703-8","article-title":"The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial","volume":"28","author":"Spertus","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ahj.2023.01.004_bib0031","unstructured":"Apple. Apple Watch. Helping your patients identify early warning signs. https:\/\/www.apple.com\/healthcare\/apple-watch\/. [accessed 29 January 2023]."},{"key":"10.1016\/j.ahj.2023.01.004_bib0032","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.ahj.2023.01.004_bib0033","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2023.01.004_bib0034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ahj.2023.01.004_bib0035","first-page":"613","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ\u20134","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ahj.2023.01.004_bib0036","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","article-title":"The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years","volume":"45","author":"Cella","year":"2007","journal-title":"Medical Care"},{"key":"10.1016\/j.ahj.2023.01.004_bib0037","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ahj.2023.01.004_bib0038","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2023.01.004_bib0039","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1590\/S1980-57642012DN06040004","article-title":"Memory complaint scale (MCS). Proposed tool for active systematic search","volume":"6","author":"Vale","year":"2012","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2023.01.004_bib0041","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2023.01.004_bib0042","first-page":"S13","article-title":"Standards of medical care in diabetes\u20132009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2023.01.004_bib0043","doi-asserted-by":"crossref","first-page":"e0251963","DOI":"10.1371\/journal.pone.0251963","article-title":"Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults","volume":"16","author":"Nikolovski","year":"2021","journal-title":"PLoS One"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:09:34Z","timestamp":1757570974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"alternative-id":["S0002870323000145"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}